Acute gastroenteritis (AGE) in the pediatric population remains a significant cause of pediatric patient morbidity and mortality. For these patients, oral rehydration therapy is an intervention that ...

A standardized treatment plan for acute viral gastroenteritis (AGE) can reduce both treatment time and unnecessary resource utilization, according to a poster presented virtually by Brent A Johnstone, ...

Please provide your email address to receive an email when new articles are posted on . Postdischarge ondansetron reduced vomiting and disease severity among children with acute gastroenteritis.

No benefits seen with Lactobacillus rhamnosus GG or L. rhamnosus R0011 and L. helveticus R0052. HealthDay News — For children with acute gastroenteritis, probiotics show no significant benefit vs ...

Researchers found that moderate-to-severe gastroenteritis occurred in 5.1% of 452 participants in the ondansetron group and in 12.5% of 441 participants in the placebo group. HealthDay News — For ...

Most children seeking emergency department (ED) care due to vomiting are discharged home. Although they usually feel better when they leave the ED, the vomiting recurs in nearly one-third of children.

Ondansetron improves outcomes when administered in EDs to children with acute gastroenteritis–associated vomiting, but the benefit of postdischarge administration is unclear. New research findings are ...

In 2006, a Cochrane Review noted that there was "weak and unreliable evidence regarding the clinical effectiveness and safety of antiemetics prescribed for children with vomiting due to AGE". [12] The ...